We are live on !
Find out more
Capital Planning Portfolio holdings
AUM
$376M
Turnover
15.05%
1-Year Est. Return
13.8%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+13.8%
3 Year Est. Return
+81.24%
5 Year Est. Return
+80.54%
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$32.7M
(+9.5%)
Cap. Flow
+$23.8M
Cap. Flow % of AUM
Cap. Flow %
6.32%
Top 10 Holdings %
Top 10 Hldgs %
58.2%
Holding
93
New
5
Increased
21
Reduced
32
Closed
9
Avg Time Held
3.6
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanta Services
PWR
|
+$27.5M |
| 2 |
SpaceX
SPCX
|
+$1.36M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.2M |
| 4 |
BlackRock Intermediate Muni Income Bond ETF
INMU
|
+$759K |
| 5 |
Vanguard Morningstar Growth ETF
VUG
|
+$527K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.92M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$642K |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$591K |
| 4 |
Abbott
ABT
|
+$528K |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$501K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.51% |
| 2 | Technology | 11.17% |
| 3 | Industrials | 11.09% |
| 4 | Healthcare | 1.09% |
| 5 | Consumer Staples | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Capital Group Core Plus Income ETF
CGCP
$8.58B
| $574K | 0.15% |
27,126
-1,128
| -4% | -$24.7K |
2022 Q2
17 quarters
|
|
52
Alphabet (Google) Class A
GOOGL
$3.47T
| $574K | 0.15% |
1,668
+116
| +7% | +$40.3K |
2024 Q1
10 quarters
|
|
53
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $574K | 0.15% |
7,071
+3,926
| +125% | +$316K |
2025 Q3
4 quarters
|
|
54
Capital Group US Multi-Sector Income ETF
CGMS
$5.55B
| $571K | 0.15% |
21,760
+98
| +0.5% | +$2.65K |
2025 Q4
3 quarters
|
|
55
JPMorgan Equity Premium Income ETF
JEPI
$46.4B
| $516K | 0.14% |
9,170
+3,130
| +52% | +$179K |
2023 Q2
13 quarters
|
|
|
56
Abbott
ABT
$181B
| $513K | 0.14% |
5,195
-5,057
| -49% | -$528K |
2020 Q4
23 quarters
|
|
57
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $508K | 0.14% |
7,067
| – | – |
2020 Q4
23 quarters
|
|
58
Eli Lilly
LLY
$1.22T
| $477K | 0.13% |
412
| – | – |
2024 Q1
10 quarters
|
|
59
iShares Core MSCI EAFE ETF
IEFA
$191B
| $474K | 0.13% |
4,892
-2,058
| -30% | -$203K |
2020 Q4
23 quarters
|
|
60
PACCAR
PCAR
$53.9B
| $458K | 0.12% |
4,169
| – | – |
2020 Q4
23 quarters
|
|
61
Global X S&P 500 Catholic Values ETF
CATH
$1.38B
| $448K | 0.12% |
4,937
| – | – |
2023 Q4
11 quarters
|
|
62
Capital Group Dividend Value ETF
CGDV
$40.1B
| $444K | 0.12% |
9,057
| – | – |
2022 Q3
16 quarters
|
|
63
Toews Agility Shares Managed Risk ETF
MRSK
$325M
| $437K | 0.12% |
11,069
| – | – |
2022 Q2
17 quarters
|
|
64
Vanguard Total World Stock ETF
VT
$81.9B
| $428K | 0.11% |
2,709
+895
| +49% | +$142K |
2026 Q1
2 quarters
|
|
65
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $413K | 0.11% |
6,955
| – | – |
2022 Q2
17 quarters
|
|
66
Celestica
CLS
$35.7B
| $370K | 0.1% |
1,025
| – | – |
2025 Q3
4 quarters
|
|
67
Amphenol
APH
$202B
| $368K | 0.1% |
4,360
+114
| +3% | +$9.18K |
2025 Q2
5 quarters
|
|
68
HP
HPQ
$28.7B
| $348K | 0.09% |
11,008
| – | – |
2020 Q4
23 quarters
|
|
69
Leatherback Long/Short Alternative Yield ETF
LBAY
$17.5M
| $336K | 0.09% |
13,505
| – | – |
2022 Q2
17 quarters
|
|
70
Advanced Micro Devices
AMD
$925B
| $330K | 0.09% |
539
| – | – |
2026 Q2
1 quarter
|
|
71
Vanguard Total Bond Market
BND
$164B
| $328K | 0.09% |
4,675
| – | – |
2024 Q4
7 quarters
|
|
72
Vanguard Core Plus Bond ETF
VPLS
$2.02B
| $328K | 0.09% |
4,428
| – | – |
2024 Q4
7 quarters
|
|
73
JPMorgan Chase
JPM
$912B
| $327K | 0.09% |
989
-25
| -2% | -$8.74K |
2023 Q1
14 quarters
|
|
|
74
Schwab US Dividend Equity ETF
SCHD
$120B
| $297K | 0.08% |
9,124
-14,874
| -62% | -$501K |
2022 Q4
15 quarters
|
|
75
ExxonMobil
XOM
$754B
| $275K | 0.07% |
1,689
+18
| +1% | +$2.81K |
2026 Q1
2 quarters
|
|
Similar funds
Capital Planning's Q3 2026 Portfolio in Review
As of Q3 2026, Capital Planning held 93 positions worth $376M, up 9.5% from $343M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Capital Planning deployed $23.8M of net new capital in Q3 2026, opening 5 new positions and adding to 21 existing holdings. Its largest new stake was SpaceX: 9,806 shares worth $1.48M.
By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 82% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $1.92M trimmed.
- Capital Planning's largest Q3 2026 buy was SpaceX: 9,806 shares worth $1.48M.
- Capital Planning added most to Quanta Services in Q3 2026, an estimated $27.5M increase.
- Capital Planning's biggest Q3 2026 reduction was AbbVie, cutting an estimated $1.92M.
- Capital Planning fully exited Schwab U.S Small- Cap ETF in Q3 2026, selling an estimated $479K.
- Capital Planning's ten largest holdings make up 58% of its $376M portfolio in Q3 2026.
- Capital Planning opened 5 new positions and closed 9 in Q3 2026.
- Capital Planning's portfolio value rose 9.5% quarter-over-quarter to $376M.
Based on Capital Planning's 13F filing for Q3 2026, filed 9 Oct 2026.